SeaCrest Wealth Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,500
Closed -$162K 923
2022
Q2
$162K Hold
6,500
0.02% 681
2022
Q1
$219K Buy
+6,500
New +$214K 0.03% 628
2019
Q2
Sell
-2,100
Closed -$85K 972
2019
Q1
$85K Buy
2,100
+400
+24% +$14.9K 0.01% 754
2018
Q4
$55K Buy
1,700
+514
+43% +$20.7K 0.01% 863
2018
Q3
$61K Hold
1,186
0.01% 923
2018
Q2
$60K Sell
1,186
-180
-13% -$9.13K 0.01% 904
2018
Q1
$70K Sell
1,366
-1,554
-53% -$82.9K 0.01% 826
2017
Q4
$153K Buy
+2,920
New +$145K 0.03% 578

Other funds holding FMS

SeaCrest Wealth Management's FMS Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Fresenius Medical Care (FMS) in Q3 2022, closing a stake of 6,500 shares — an estimated $162K sold.

SeaCrest Wealth Management first reported a position in FMS in Q4 2017 and held it in 8 quarters. The position peaked at $219K in Q1 2022. 141 funds tracked by Wall St. Rank hold FMS as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining Fresenius Medical Care position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 6,500 Fresenius Medical Care shares in Q3 2022, an estimated $162K.
  • SeaCrest Wealth Management first reported a position in Fresenius Medical Care in Q4 2017 and held it in 8 quarters.
  • SeaCrest Wealth Management's Fresenius Medical Care position peaked at $219K in Q1 2022.
  • 141 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.